title: Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
abstract: BACKGROUND
  There are few prospective data available for establishing a standard diuretic administration regimen for patients with acute decompensated heart failure (ADHF). We aimed to assess the safety and efficacy of three regimens of furosemide administration in patients with ADHF with regard to diuresis, renal functions, and in-hospital outcomes.
  
  
  METHODS
  A total of 43 patients who presented with ADHF were randomized into three groups: (a) continuous infusion (cIV) of 160 mg furosemide for 16 h/day (n = 15); (b) bolus injections (bI) of 80 mg furosemide twice a day (n = 14); (c) and administration of 160 mg furosemide plus hypertonic saline solution (HSS) as an infusion for 30 min once a day (n = 14). All regimens were continued for 48 h. Study endpoints were negative fluid balance assessed by loss of body weight, change in the serum creatinine (baseline to 48 h and baseline to compensated state), and length of hospitalization.
  
  
  RESULTS
  There was no significant difference in the mean change in serum creatinine level at the end of 48 h between groups (p = 0.08). There was also no significant difference among groups regarding loss of body weight (p = 0.66). A significantly shorter hospitalization was observed in patients treated with HSS compared with the other groups (cIV group 6.6 ± 3.4 days vs. bI group 7.9 ± 4.1 days vs. HSS group 3.7 ± 1.3 days; p < 0.01).
  
  
  CONCLUSIONS
  All three furosemide regimens have similar renal safety and efficacy measures. However, administration of furosemide plus HSS may be the preferred diuretic strategy because of its shorter hospital stay.
authors.affiliation: Department of Cardiology, Türkiye Yüksek Ihtisas Education and Research Hospital, Ankara, Turkey. cagriyayla@gmail.com.|Türkiye Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, 06100, Sihhiye/Ankara, Turkey. cagriyayla@gmail.com.
authors.forename: Çağrı
authors.initials: Ç
authors.lastname: Yayla
authors.affiliation: Department of Cardiology, Dişkapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Akyel
authors.affiliation: Department of Cardiology, Türkiye Yüksek Ihtisas Education and Research Hospital, Ankara, Turkey.
authors.forename: Uğur
authors.initials: U
authors.lastname: Canpolat
authors.affiliation: Department of Cardiology, Dişkapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
authors.forename: Kadriye
authors.initials: K
authors.lastname: Gayretli Yayla
authors.affiliation: Department of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
authors.forename: Azmi
authors.initials: A
authors.lastname: Eyiol
authors.affiliation: Department of Cardiology, Türkiye Yüksek Ihtisas Education and Research Hospital, Ankara, Turkey.
authors.forename: Mehmet Kadri
authors.initials: MK
authors.lastname: Akboğa
authors.affiliation: Department of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
authors.forename: Sedat
authors.initials: S
authors.lastname: Türkoğlu
authors.affiliation: Department of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Tavil
authors.affiliation: Department of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
authors.forename: Bülent
authors.initials: B
authors.lastname: Boyacı
authors.affiliation: Department of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
authors.forename: Atiye
authors.initials: A
authors.lastname: Çengel
mesh_terms: D000208:Acute Disease; D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D004232:Diuretics / Q000008:administration & dosage*; D005260:Female; D005665:Furosemide / Q000008:administration & dosage*; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D005665:Furosemide
keywords: Acute heart failure syndrome; Diuretic therapy; Furosemide; Hospitalization; Renal safety profile